SPOTLIGHT: Who's the best CEO of them all?
Who'll brave the pitfalls of generic competition and restless shareholders and pipeline pressure to be the last Big Pharma/Big Biotech CEO standing? That's what the WSJ Health Blog is asking with a new tourney bracket pitting the likes of Pfizer's Jeff Kindler (photo) and Genentech's Arthur Levinson (photo) against one another. Fill in the blanks to reach your own conclusions. Report
Be the first to comment Rate it:
Comments
Post new comment
Paid Research Reports
- Pipeline Insight: Nosocomial Vaccines - Minefield or Goldmine?
- Drug Approval Trends at the FDA and EMEA: Process improvements, heightened scrutiny and industry response
- Biotech 2008 – life sciences industry report (online & print)
- Is there a market for alcoholism pharmacotherapies?
- New report provides Rheumatoid Arthritis market insight